Titan Pharmaceuticals to Participate in RBC Capital Markets Global Healthcare Conference February 23, 2012
Titan Pharmaceuticals Announces Positive Results of Six-Month Open-Label Safety Retreatment Study of Probuphine February 9, 2012
Titan Pharmaceuticals Adopts Stockholder Rights Plan, Files Shelf Registration of Securities on Form S-3 December 21, 2011
Titan Pharmaceuticals Announces Probuphine Presentation at American Society of Addiction Medicine Conference October 20, 2011
Titan Pharmaceuticals Provides Additional Positive Results in Confirmatory Phase 3 Trial of Probuphine August 16, 2011
Titan Pharmaceuticals Schedules Conference Call to Review Second Quarter 2011 Financial Results and Probuphine Phase 3 Clinical Study Results August 9, 2011
Titan Pharmaceuticals Announces Positive Top Line Results in Confirmatory Phase 3 Trial of Probuphine July 11, 2011
